Arete Wealth Advisors »

Bioxcel Therapeutics shares owned by Arete Wealth Advisors

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Arete Wealth Advisors from 13F filings

Historical chart of Arete Wealth Advisors investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Arete Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Arete Wealth Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $322k 109k 2.95

More positions owned by Arete Wealth Advisors

Abbvie (ABBV)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Apple (AAPL)
Disney Walt Com Disney (DIS)
Abbott Laboratories (ABT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Fs Kkr Capital Corp (FSK)
Spdr Gold Trust Gold Shs (GLD)
Spdr Ser Tr Spdr Bloomberg (BIL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Ishares Tr Shrt Trs Bd Etf (SHV)

View all positions for Arete Wealth Advisors

Top funds holding Bioxcel Therapeutics

Vanguard Group
Beacon Pointe Advisors
Charles Schwab Investment Management
Citadel Advisors
Bank of New York Mellon
Arete Wealth Advisors
Bank of America Corporation
Bank Of Montreal
Millennium Management
Wells Fargo & Company
Virtu Financial
Squarepoint Ops
Tocqueville Asset Management
UBS Group
D. E. Shaw & Co

View all funds holding Bioxcel Therapeutics